company

JD Wetherspoon

FAIRR Commentary

JD Wetherspoon has a policy that prohibits the prophylactic use of critically important antibiotics to human medicine across all species and geographies.  Their policy now covers all relevant species, including seafood. The company is working to develop species-specific reduction targets including relevant metrics for data collection, using Compassion in World Farming (CIWF) Antibiotic Stewardship Programme as a blueprint.  However, the company has yet to report publicly on implementation progress and it continues to monitor supplier compliance through internal audits only.

FAIRR Recommendations

We are encouraged by JD Wetherspoon’s commitment to antibiotics stewardship. However, we would encourage the company to further strengthen their programme by:

  • Clarifying whether their policy covers all suppliers across all relevant jurisdictions.
  • Extending the scope of their policy beyond critically important antibiotics in order to phase out the routine use of all antibiotics and/ or only use antibiotics when there is a disease present and administered by a veterinarian.
  • Using stronger language i.e. “prohibit or phase out” rather than “not support” routine prophylactic use.
  • Committing to third-party audits across all relevant markets and species to ensure supplier compliance
  • Reporting more comprehensively and publicly on implementation progress including antibiotics use.

Company Comment

The policy is being developed year on year with the first step to eliminate the use of critically important antibiotics before developing the policy further to include the additional categories. Our audits review the suitability of our suppliers’ antibiotics policies. Traceability exercises are also completed at each audit to confirm these policies are in place.  Our audits review the suitability of our suppliers’ antibiotics policies. Traceability exercises are also completed at each audit to confirm these policies are in place.

See the company’s response to the engagement here.